APARTMENT INVT & MGMT CO -A (AIV)

US03748R7474 - REIT

8.24  +0.13 (+1.6%)

Fundamental Rating

1

Overall AIV gets a fundamental rating of 1 out of 10. We evaluated AIV against 21 industry peers in the Residential REITs industry. AIV may be in some trouble as it scores bad on both profitability and health. AIV has a expensive valuation and it also scores bad on growth.



2

1. Profitability

1.1 Basic Checks

In the past year AIV has reported negative net income.
AIV had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: AIV reported negative net income in multiple years.
AIV had a positive operating cash flow in each of the past 5 years.

1.2 Ratios

Looking at the Return On Assets, with a value of -7.95%, AIV is doing worse than 95.24% of the companies in the same industry.
AIV has a worse Return On Equity (-47.53%) than 90.48% of its industry peers.
The Return On Invested Capital of AIV (0.49%) is worse than 90.48% of its industry peers.
Industry RankSector Rank
ROA -7.95%
ROE -47.53%
ROIC 0.49%
ROA(3y)-1.59%
ROA(5y)0.36%
ROE(3y)-11.7%
ROE(5y)-1.99%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Operating Margin of AIV (6.19%) is worse than 90.48% of its industry peers.
In the last couple of years the Operating Margin of AIV has declined.
AIV has a Gross Margin (60.62%) which is comparable to the rest of the industry.
In the last couple of years the Gross Margin of AIV has declined.
Industry RankSector Rank
OM 6.19%
PM (TTM) N/A
GM 60.62%
OM growth 3Y84.27%
OM growth 5Y-22.52%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.69%
GM growth 5Y-1.75%

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), AIV is destroying value.
AIV has less shares outstanding than it did 1 year ago.
AIV has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, AIV has a worse debt to assets ratio.

2.2 Solvency

Based on the Altman-Z score of 0.46, we must say that AIV is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 0.46, AIV is not doing good in the industry: 76.19% of the companies in the same industry are doing better.
A Debt/Equity ratio of 3.62 is on the high side and indicates that AIV has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 3.62, AIV is doing worse than 90.48% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 3.62
Debt/FCF N/A
Altman-Z 0.46
ROIC/WACC0.08
WACC6.14%

2.3 Liquidity

AIV has a Current Ratio of 1.57. This is a normal value and indicates that AIV is financially healthy and should not expect problems in meeting its short term obligations.
AIV has a better Current ratio (1.57) than 80.95% of its industry peers.
AIV has a Quick Ratio of 1.57. This is a normal value and indicates that AIV is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.57, AIV belongs to the top of the industry, outperforming 80.95% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.57
Quick Ratio 1.57

0

3. Growth

3.1 Past

AIV shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -375.14%.
Looking at the last year, AIV shows a decrease in Revenue. The Revenue has decreased by -1.76% in the last year.
The Revenue for AIV have been decreasing by -28.09% on average. This is quite bad
EPS 1Y (TTM)-375.14%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q19.92%
Revenue 1Y (TTM)-1.76%
Revenue growth 3Y7.27%
Revenue growth 5Y-28.09%
Revenue growth Q2Q17.5%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-150%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year10.82%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

AIV reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year AIV is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, AIV is valued more expensive than 90.48% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 28.83

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for AIV!.
Industry RankSector Rank
Dividend Yield N/A

APARTMENT INVT & MGMT CO -A

NYSE:AIV (5/3/2024, 8:50:59 AM)

8.24

+0.13 (+1.6%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryResidential REITs
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap1.19B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -7.95%
ROE -47.53%
ROCE
ROIC
ROICexc
ROICexgc
OM 6.19%
PM (TTM) N/A
GM 60.62%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.09
Health
Industry RankSector Rank
Debt/Equity 3.62
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.57
Quick Ratio 1.57
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-375.14%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y-150%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-1.76%
Revenue growth 3Y7.27%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y